Eduardo Sabino de Camargo Magalhães
5PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.Samarpana Chakraborty, Claudia Morganti, Kimberly Zaldana
|Mar 27, 2024
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy.Eduardo Sabino de Camargo Magalhães, Stefan Edward Hubner, Brandon Douglas Brown
|Mar 29, 2023
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.Stefan E Hubner, Eduardo S de Camargo Magalhães, Fieke W Hoff
|May 10, 2022
The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity.Marlinde J Smit, Tosca E I Martini, Inna Armandari
|Nov 09, 2021
The H3.3K27M oncohistone affects replication stress outcome and provokes genomic instability in pediatric glioma.Irena Bočkaj, Tosca E I Martini, Eduardo S de Camargo Magalhães
Pageof 1
Frequent Collaborators
3 joint publications
Steven Mitchell Kornblau
2 joint publications
Irena Bočkaj
2 joint publications
Tosca E I Martini
2 joint publications
Inna Armandari
2 joint publications
Sophia W M Bruggeman
1 joint publications
Saskia L Meuleman
1 joint publications
Marin T Mondria
1 joint publications
Colin Stok
1 joint publications
Aditi Shastri
1 joint publications
Bjorn Bakker
